Sponsor:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- Notice of Participation of ECHO in RFA-ES-18-011 "Human Health Exposure Analysis Resource: Targeted Exposure Analysis Laboratories (U2C Clinical Trial Not Allowed)"
National Institutes of Health - Notice of Participation of ECHO in RFA-ES-18-012 "Human Health Exposure Analysis Resource: Untargeted Exposure Analysis Laboratories (U2C Clinical Trial Not Allowed)"
National Institutes of Health - Notice of Participation of ECHO in RFA-ES-18-013 "Human Health Exposure Analysis Resource: Environmental Monitoring Laboratories (U2C Clinical Trial Not Allowed)"
National Institutes of Health - NIH & AHRQ Announce Upcoming Updates to Application Instructions and Review Criteria for Fellowship Award Applications
National Institutes of Health - NIH & AHRQ Announce Upcoming Updates to Application Instructions and Review Criteria for Research Grant Applications
National Institutes of Health - NIH & AHRQ Announce Upcoming Updates to Application Instructions and Review Criteria for Career Development Award Applications
National Institutes of Health - Reminder: NIH Natural Disaster Policy - Hurricane Florence
National Institutes of Health - Notice of Early Expiration of PAR-17-048 "Phylodynamic Tracking of HIV Transmission (R01)"
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Mental Health - Request for Information (RFI) on the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Strategic Plan for Fiscal Years (FY) 2020-2024
National Institute of Arthritis and Musculoskeletal and Skin Diseases - Notice of Change to Key Dates in PAR-18-249 "Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional)"
National Cancer Institute - Notice of Change to the Eligibility of Foreign Components in PA-18-060, " Neuroscience Research on Drug Abuse (R01)"
National Institute on Drug Abuse - Notice of Change to the Eligibility of Foreign Components in PA-18-078, " Neuroscience Research on Drug Abuse (R21)"
National Institute on Drug Abuse - Development of New Antibacterial Drugs Active Against Multi-Drug Resistant Bacteria
Food and Drug Administration - Notice of NICHD's Participation in PA-18-817 "Administrative Supplements for Research on Dietary Supplements (Admin Supp - Clinical Trial Not Allowed)"
Eunice Kennedy Shriver National Institute of Child Health and Human Development - Notice of Change in Expiration Date for PAR-18-853 "Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical Trial Not Allowed)"
Eunice Kennedy Shriver National Institute of Child Health and Human Development - Notice of Pre-Application Technical Assistance Webinar for RFA-MD-18-011, Limited Competition: RCMI Research Coordination Network (RRCN) (U54 Clinical Trial Not Allowed)
National Institute on Minority Health and Health Disparities - Notice of Intent to Publish a Funding Opportunity Announcement to Support Institutional Translational Research Training Programs (T32)
National Institute of Neurological Disorders and Stroke - Notice of Intent to Publish a Funding Opportunity Announcement for NINDS Exploratory Grant for Morris K. Udall Center without Walls for Parkinsons Disease Research (P20)
National Institute of Neurological Disorders and Stroke - Notice of Intent to Publish a Funding Opportunity Announcement for NINDS Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50)
National Institute of Neurological Disorders and Stroke - Notice of Intent to Publish a Funding Opportunity Announcement to Support NINDS-Specific Institutional Research Training Programs (T32)
National Institute of Neurological Disorders and Stroke - Notice of Intent to Publish a Funding Opportunity Announcement for Post-Stroke VCID in the United States Including in Health Disparities Populations (U19 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Institute on Aging - Notice of Correction to application forms package for PA-17-326 "Administrative Supplements for the U.S.-Japan Brain Research Cooperative Program (BRCP) - U.S. Entity (Admin Supplement)"
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health - Notice of Change to Receipt Date on Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 Clinical Trial Not Allowed) (PAR-18-909)
National Center for Advancing Translational Sciences
Requests for Applications
- Clinician-Scientists Transdisciplinary Aging Research (Clin-STAR) Coordinating Center: Synergizing Career Development toward Improved Care of Older Adults across Specialties and Disciplines (U24 - Clinical Trial Optional)
National Institute on Aging
- Communication and Decision Making for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Optional).
National Cancer Institute
- Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54 Clinical Trial Not Allowed)
National Cancer Institute
- Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01- Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
- Limited Competition for the Continuation of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Research Sites (U01 Clinical Trial Not Allowed)
- Limited Competition for the Continuation of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Data Coordinating Center (U24 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases.
- Screening and Management of Unhealthy Alcohol Use in Primary Care: Dissemination and Implementation of PCOR Evidence (R18)
Agency for Healthcare Research and Quality
Program Announcements
- AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
National Institute on Drug Abuse
- Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NCCIH Supplements to NCATS CTSA Programs for Scholars Pursuing Complementary Health Research Career Development (Admin Supp Clinical Trial Optional)
National Center for Complementary and Integrative Health
National Center for Advancing Translational Sciences
- Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
National Institute on Drug Abuse
- Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)
National Cancer Institute
- HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional)
National Institute on Drug Abuse
Details, including application deadlines, when applicable, are available through the program links above. To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Paul Below at paul-below@uiowa.edu, or Lynn Hudachek at lynn-hudachek @uiowa.edu, or Erin Brothers at erin-brothers@uiowa.edu.